Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on April 20, 2006, to report on its financial condition and operational developments. The filing includes details from a press release announcing the company's financial results for the quarter ended March 31, 2006. While the specific financial figures from the press release are not detailed in this 8-K's text, investors are directed to Exhibit 99.1 for this information, suggesting a general update on performance. More significantly, the report announces a major operational decision: Quest Diagnostics has decided to discontinue the operations of its test kit manufacturing subsidiary, NID. This decision follows repeated quality issues and product holds that have negatively impacted NID's performance. The company expects to incur a pre-tax charge of up to $45 million in the second quarter of 2006, primarily for asset write-offs and employee severance, with estimated cash expenditures of up to $35 million.
Key Highlights
- 1Quest Diagnostics announced its financial results for the quarter ended March 31, 2006, via a press release (Exhibit 99.1).
- 2The company has decided to discontinue operations of its test kit manufacturing subsidiary, NID.
- 3The decision to discontinue NID's operations is a result of ongoing quality issues and product holds.
- 4A pre-tax charge of up to $45 million is anticipated in the second quarter of 2006 related to the NID exit.
- 5Estimated cash expenditures associated with the NID discontinuation are up to $35 million.
- 6The charge will primarily cover the write-off of operating assets and employee severance costs.
- 7Liabilities associated with various lease commitments are also expected to contribute to the charge.